Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06980012

Evaluation of the Impact of the Clinical Pharmacist in Oral Therapies in Oncology.

Evaluation of the Impact of the Clinical Pharmacist in the Initiation and Follow-up of Oral Therapies in Oncology.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Polyclinique Lyon Nord · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The hospital pharmacist plays a vital role at the time of the patient's first prescription in a healthcare facility, to inform the patient about his or her new therapy and create a link between the hospital and the patient's home pharmacy, so that the patient can continue to receive care at home. It is also essential that the hospital pharmacy and the patient's local pharmacy work together within a reasonable timeframe. This will help improve patient care and treatment follow-up, detect any undesirable effects and optimize their management.. The aim of this prospective interventional study is to measure the benefits of pharmaceutical monitoring in healthcare institutions at the initiation of oral therapy on patient compliance, side-effect management and adherence, in comparison with patients without this monitoring. The primary endpoint is compliance with the Girerd questionnaire.

Conditions

Interventions

TypeNameDescription
PROCEDUREPharmaceutical consultationThe pharmaceutical interview is a structured way of carrying out an optimized medication review with the patient. This interview takes place at the time of the first prescription of oral anti-cancer treatment.
PROCEDUREPharmaceutical consultation and follow-upAfter the first prescription and at the treatment renewal date (+/- 2 days), the hospital pharmacist will contact the dispensing pharmacist to inform him/her of the patient's treatment, and then as part of the follow-up to detect any problems with treatment compliance (non-renewal of treatment by the patient, lack of follow-up, complaints of adverse effects by the patient). These events will be recorded in the observation book.

Timeline

Start date
2024-12-31
Primary completion
2026-06-30
Completion
2026-09-30
First posted
2025-05-20
Last updated
2025-08-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06980012. Inclusion in this directory is not an endorsement.

Evaluation of the Impact of the Clinical Pharmacist in Oral Therapies in Oncology. (NCT06980012) · Clinical Trials Directory